PTC923

Drug identity checked against registry records

Also recorded as Sephience; Sepiapterin

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of PTC923 in Participants With PhenylketonuriaNCT05099640PTC TherapeuticsPhase 3Completed2023-04-03Actual
A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaNCT05166161PTC TherapeuticsPhase 3Completed2026-07-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.